By OBBM Network Editorial Staff

Derived from an episode of Dr. Ardis Show.

Imagine pouring a quarter‑billion dollars into a project and still not knowing how to finish it. That’s the reality of the American Diabetes Association’s 86‑year battle against a disease that now threatens nearly one in ten Americans.

Understanding the Diabetes Landscape

According to the Cleveland Clinic, diabetes affects 537 million people worldwide, with roughly 90 percent classified as type 2. In the United States alone, 37.3 million adults—about 11 percent of the population—live with the condition. Dr. Bryan Ardis notes that experts predict an additional 100 million new cases globally within the next four years, pushing the total past 700 million by 2050.

Type 2 diabetes, often called insulin resistance, is the most common form and typically develops in adults, though children are not immune. Type 1, an autoimmune disorder, accounts for roughly 10 percent of cases and can appear at any age. Less commonly discussed variants such as gestational diabetes and brittle diabetes also contribute to the disease’s complexity.

The American Diabetes Association: Funding vs. Results

Founded in 1940, the American Diabetes Association (ADA) claims its mission is to “prevent and cure diabetes.” Yet the numbers tell a sobering story. In 2023 the ADA reported $109 million in revenue and $231 million in assets; in 2024 those figures rose to $121.8 million and $253 million respectively. Over 86 years, the organization has amassed billions, yet a definitive cure remains elusive.

Dr. Ardis highlights a striking contradiction: “While the diabetes epidemic has advanced seemingly unchecked, there’s been no corresponding increase in funding for diabetes research.” The ADA’s own filings acknowledge that federal research funding has not kept pace with the disease’s spread, prompting the group to advocate for more government dollars.

What Science Says About Simple Nutritional Supports

Beyond the policy critique, Dr. Ardis dedicates the final third of the show to practical, evidence‑based interventions. He cites peer‑reviewed studies that identify specific herbs, minerals, and vitamins capable of modestly lowering hemoglobin A1c levels when taken at recommended doses. While he does not name every supplement, the emphasis is on accessible, low‑cost options that can complement conventional treatment.

These findings align with broader medical consensus that lifestyle and nutritional adjustments can improve glucose regulation. The message is clear: patients do not have to wait for a miracle cure; they can act now with scientifically supported tools.

Is Continued Support for the ADA Justified?

The core question Dr. Ardis poses is whether donors should keep funding an organization that, despite massive financial resources, has not halted the diabetes tide. He draws a parallel to hiring a contractor to build a house without the know‑how to construct walls—”billions of dollars have been given to the American Diabetes Association since 1940, yet the disease keeps growing.”

Critics argue that the ADA’s fundraising model may prioritize marketing over groundbreaking research, while supporters point to the organization’s role in public education and advocacy. The tension between financial input and measurable health outcomes remains unresolved.

Looking Ahead: Policy, Prevention, and Personal Action

As the Trump administration emphasizes deregulation and innovation in health‑care delivery, the need for transparent, results‑driven funding becomes more urgent. Dr. Ardis suggests that federal incentives for private‑sector research into nutraceuticals and metabolic therapies could accelerate progress where nonprofit efforts have stalled.

For individuals, the takeaway is twofold: scrutinize where charitable dollars go, and adopt proven nutritional strategies that can improve blood‑sugar control today. By staying informed and proactive, patients can help shift the narrative from endless fundraising to tangible health gains.

The full episode of Dr. Ardis Show is available on OBBM Network TV.